Loading clinical trials...
Loading clinical trials...
To evaluate the safety of Levetiracetam IV 15-minute infusion administered every 12 hours as adjunctive treatment in subjects with Partial Onset Seizures after switching from the equivalent Levetirace...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
UCB Japan Co. Ltd.
NCT06608966 · Epilepsy in Children, Executive Dysfunction
NCT06455384 · Cardiac Conditions, Connective Tissue Diseases, and more
NCT05140265 · Epilepsy, Status Epilepticus, and more
NCT06059157 · Drug Resistant Epilepsy
NCT07116421 · Epilepsy, Sudden Unexpected Death in Epilepsy
1
Niigata, Niigata
2
Shizuoka, Shizuoka
3
Kodaira, Tokyo
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions